Navigation Links
ShengdaTech to Present at Rodman & Renshaw Annual China Investment Conference in Shanghai
Date:2/28/2011

SHANGHAI, Feb. 28, 2011 /PRNewswire-Asia-FirstCall/ -- ShengdaTech, Inc. ("ShengdaTech" or the "Company") (NASDAQ: SDTH), a leading manufacturer of nano-precipitated calcium carbonate ("NPCC") in China, today announced that Mr. Xiangzhi Chen, the Company's chairman and CEO, Ms. Anhui Guo, COO and acting CFO and Mr. A. Carl Mudd, lead independent director, will attend the Rodman & Renshaw Annual China Investment Conference to be held from March 6-8, 2011 in Shanghai.

The date, time, and location of ShengdaTech's presentation at the Conference are as follows:Date:Tuesday, March 8, 2011Time:  

11:30 a.m. Presenter:

Crocker Coulson, President of CCG Investor RelationsLocation:  

Ballroom II, Le Royal Meridien, Shanghai, ChinaA copy of ShengdaTech's investor presentation will be made available online at: http://www.shengdatechinc.com on the day it is presented.

The Rodman & Renshaw's 2011 Annual China Investment Conference will feature diverse industry sectors, including Agriculture, Automotive, Cleantech & Energy, Consumer, Education, Healthcare, Industrial, Metals & Mining, and Technology. The conference is expected to attract over 150 public and private companies and more than 1,000 attendees. For more information about the conference and registration, please visit www.rodm.com/conferences.  

Investors who wish to meet with ShengdaTech's management may contact Rodman & Renshaw or ShengdaTech's IR representative in the U.S., Roger Ellis at +1 (310) 954 1332 or roger.ellis@ccgir.com.

About ShengdaTech, Inc.  ShengdaTech is engaged in the business of manufacturing, marketing, and selling nano-precipitated calcium carbonate ("NPCC") products. The Company converts limestone into NPCC using its proprietary and patent-protected technology. NPCC products are increasingly used in tires, paper, paints, building materials, and other chemical products. In addition to its broad customer base in China, the Company currently exports to Singapore, Thailand, South Korea, Malaysia, India and Latvia. For more information, contact CCG Investor Relations directly or go to ShengdaTech's website at http://www.shengdatechinc.com.

Contact:Anhui Guo, Chief Operating OfficerShengdaTech, Inc.gah@shengdatech.com www.shengdatechinc.comCCG Investor RelationsCrocker Coulson, PresidentTel:   +1-646-213-1915 (NY office)Email: crocker.coulson@ccgir.com www.ccgirasia.comElaine Ketchmere, PartnerTel:   +1-310-954-1345 (LA office)Email: elaine.ketchmere@ccgir.com
'/>"/>

SOURCE ShengdaTech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. InterMune to Present at Canaccord Adams Conference
2. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
3. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. Bionovo to Present at Canaccord Adams Global Growth Conference
6. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
7. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
8. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
9. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
10. Duska Therapeutics to Present at Noble Financial Equity M.A.D. MAX Conference on Tuesday, August 19th at 1:30 p.m. PDT
11. Cepheid to Webcast Upcoming Financial Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016  In the pharmaceutical industry the medical affairs ... launch activities including the identification and engagement of key ... especially high in the oncology therapeutic area where most ... the Role of Medical Affairs in Oncology Launch Excellence ... therapies find better ways to utilize medical affairs to ...
(Date:2/5/2016)... -- Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, announced ... from the US Food and Drug Administration (FDA) for ... granted orphan drug designation (ODD) by the US FDA ... Inc. (OTCQB: AMBS), a biotechnology company ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 --> --> Fourth ... (105.0), up 1,187% compared with fourth quarter of 2014. Gross ... M (loss: 30.0). Earnings per share increased to SEK 6.39 ... M (neg: 74.7). , --> ... SEK 2,900.5 M (233.6), up 1,142% compared with 2014. Gross ...
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):